NEW YORK (GenomeWeb News) – Direct-to-consumer genetics testing firm 23andMe today said that it has raised more than $50 million in a Series D financing round.

The funds will be used to expand the Mountain View, Calif.-based company's business with the goal of creating an "exponentially larger" group of genotyped individuals and using data from those individuals to conduct research. 23andMe currently has more than 180,000 customers and it aims to eventually reach one million, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.